Tuesday , October 17 2017
Home / KEEP BUT DO NOT DISPLAY / Alerts / Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes

Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes

Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes

See our feature article, FDA Panel Approves Inhaled Insulin, Again.